Mycobacterium tuberculosis antigen(EM)（Anbo Zhilian）
结核分枝杆菌抗原(EM)（安博智联）
Report date: 2025/07/04 20:00:55
Base Information
Drug NameMycobacterium tuberculosis antigen(EM)（Anbo Zhilian）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAnbo Zhilian (Suzhou) Biotechnology CO LTD
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesAnbo Zhilian (Suzhou) Biotechnology CO LTD
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A